Patent · US Expired

Imidazole and 1,2,4-triazole derivatives with angiotensin II antagonist properties

US5389661A · kind A · utility

25Cited by
3References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 1994
Grant dateFeb 14, 1995
Priority date
Expiry dateFeb 10, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to novel substituted imidazole and triazole derivatives which antagonize the binding of angiotensin II to its receptors. The compounds are useful in the treatment of hypertension, heart failure, glaucoma, and hyperaldosteronism. Methods of making the compounds, novel intermediates useful in the preparation of the compounds, pharmaceutical compositions containing the compounds, and methods of using them are also covered.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.